394 related articles for article (PubMed ID: 31050716)
1. Short- vs. long-term dual antiplatelet therapy in secondary prevention for ischaemic stroke: a network metanalysis.
Pugliese F; Arasaratnam P; Moellenberg M; Dani S
Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):298-309. PubMed ID: 31050716
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
4. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: Meta-analysis of randomized controlled trials.
Fanari Z; Malodiya A; Weiss SA; Hammami S; Kolm P; Weintraub WS
Cardiovasc Revasc Med; 2017; 18(1):10-15. PubMed ID: 27477306
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis.
Ding L; Peng B
Eur J Neurol; 2018 Oct; 25(10):1276-1284. PubMed ID: 29855121
[TBL] [Abstract][Full Text] [Related]
7. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
Davis KA; Miyares MA; Dietrich E
Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
[TBL] [Abstract][Full Text] [Related]
8. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of dual versus mono antiplatelet therapy in patients with stroke or transient ischemic attack: An updated meta-analysis of 18 randomized controlled trials.
Fu-Sang W; Xiao-Han Z; Yang Z; Ting-Ting C; Chao S; Jing-Yi L; Jian-Jun Z
Pharmazie; 2020 Oct; 75(10):516-523. PubMed ID: 33305729
[TBL] [Abstract][Full Text] [Related]
10. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.
Udell JA; Bonaca MP; Collet JP; Lincoff AM; Kereiakes DJ; Costa F; Lee CW; Mauri L; Valgimigli M; Park SJ; Montalescot G; Sabatine MS; Braunwald E; Bhatt DL
Eur Heart J; 2016 Jan; 37(4):390-9. PubMed ID: 26324537
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis.
Xie W; Zheng F; Zhong B; Song X
J Am Heart Assoc; 2015 Aug; 4(8):e002259. PubMed ID: 26304937
[TBL] [Abstract][Full Text] [Related]
12. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
13. Dual antiplatelet therapy after stroke or transient ischaemic attack - how long to treat? The duration of aspirin plus clopidogrel in stroke or transient ischaemic attack: a systematic review and meta-analysis.
Ge F; Lin H; Liu Y; Li M; Guo R; Ruan Z; Chang T
Eur J Neurol; 2016 Jun; 23(6):1051-7. PubMed ID: 27021849
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F
BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668
[TBL] [Abstract][Full Text] [Related]
15. P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials.
Kuno T; Ueyama H; Takagi H; Bangalore S
Am Heart J; 2020 Sep; 227():82-90. PubMed ID: 32693196
[TBL] [Abstract][Full Text] [Related]
16. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
Hao Q; Tampi M; O'Donnell M; Foroutan F; Siemieniuk RA; Guyatt G
BMJ; 2018 Dec; 363():k5108. PubMed ID: 30563866
[TBL] [Abstract][Full Text] [Related]
17. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
[TBL] [Abstract][Full Text] [Related]
18. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
Trifan G; Gorelick PB; Testai FD
Circulation; 2021 Jun; 143(25):2441-2453. PubMed ID: 33926204
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: A network meta-analysis.
Xiang RW; Han RB; Yang JY; Zhao MY; Zhao QC; Chen HS; Zhao FQ; Sun ZY; Zhao T; Song TY
J Neurol Sci; 2019 Apr; 399():199-206. PubMed ID: 30849580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]